Problem statement: Answer the MCQ question.
Query: Which drug exhibits a -0.858% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
[a] O=C(NC(=S)Nc1ccc2oc(=O)ccc2c1)c1cccc(F)c1
[b] CC(=O)N1CC(C)Sc2ccc(S(=O)(=O)NCc3ccc(Cl)cc3)cc21
[c] CCN(C(=O)CSc1nnnn1-c1ccccc1)C1CCS(=O)(=O)C1
Answer: c. CCN(C(=O)CSc1nnnn1-c1ccccc1)C1CCS(=O)(=O)C1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN(C(=O)CSc1nnnn1-c1ccccc1)C1CCS(=O)(=O)C1
CCN(C(=O)CSc1nnnn1-c1ccccc1)C1CCS(=O)(=O)C1
N-(1,1-dioxothiolan-3-yl)-N-ethyl-2-(1-phenyltetrazol-5-yl)sulfanylacetamide